![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2006 by The National Academy of Sciences of the USA Cell Biology From the Cover A rapid genome-scale response of the transcriptional oscillator to perturbation reveals a period-doubling path to phenotypic change Dynamic Systems Group, Department of Biology, Beckman Research Institute, City of Hope Medical Center, Duarte CA 91010 *To whom correspondence should be addressed. E-mail: rklevecz/at/coh.org Edited by J. Woodland Hastings, Harvard University, Cambridge, MA, and approved August 24, 2006 Author contributions: C.M.L. and R.R.K. designed research; C.M.L. performed research; C.M.L. and R.R.K. analyzed data; and R.R.K. wrote the paper. Received June 12, 2006. Freely available online through the PNAS open access option. See commentary "Discovery of principles of nature from mathematical modeling of DNA microarray data" on page 16063. This article has been cited by other articles in PMC.Abstract Perturbation of the gated-synchrony system in yeast with phenelzine, an antidepressant drug used in the treatment of affective disorders in humans, leads to a rapid lengthening in the period of the genome-wide transcriptional oscillation. The effect is a concerted, genome-scale change in expression that is first seen in genes maximally expressed in the late-reductive phase of the cycle, doubling the length of the reductive phase within two cycles after treatment. Clustering of genes based on their temporal patterns of expression yielded just three super clusters whose trajectories through time could then be mapped into a simple 3D figure. In contrast to transcripts in the late-reductive phase, most transcripts do not show transients in expression relative to others in their temporal cluster but change their period in a concerted fashion. Mapping the trajectories of the transcripts into low-dimensional surfaces that can be represented by simple systems of differential equations provides a readily testable model of the dynamic architecture of phenotype. In this system, period doubling may be a preferred pathway for phenotypic change. As a practical matter, low-amplitude, genome-wide oscillations, a ubiquitous but often unrecognized attribute of phenotype, could be a source of seemingly intractable biological noise in microarray studies. Keywords: dynamics, genome-wide, microarray, oscillation The idea that the cell is an oscillator, an attractor, and that time is an essential variable of the information content of cellular systems, although well supported by both theory and experimental findings, is still something of a novelty in genomics (1–4). Before the development of genome-wide assays, experimental support for viewing the cell as an oscillator was limited to measuring single constituents or to analyzing macroscopic events such as DNA replication or cell division after an intentional perturbation (5–7). We now have the capacity to follow the transcriptional patterns of all expressed genes to construct a system-wide dynamic network. By assessing the temporal pattern of gene expression in all of the transcripts closely through time after perturbation, we can derive the first measurements of coupling strength among genes. Such information is essential to constructing a detailed formal representation of the cellular attractor. Network representations based on two-hybrid, chip–chip, or mass spectrometry interactions (8–13) give us a sparse mapping of genes that interact but have not offered clear insights into dynamic connectivity among genes and their transcripts. Our effort here is to bring together genome-wide changes through time and the more traditional gene-centered, steady-state network perspective to uncover the dynamic architecture of phenotype. Lithium and phenelzine (PZ) are among the oldest of the mood-stabilizing or antidepressant psychoactive drugs used in the treatment of bipolar and other affective disorders in humans. It has long been known that one of the effects of these agents is a slight lengthening of the period of the circadian rhythm in both normal volunteers and patients under controlled settings (14, 15). In humans, as well as experimental systems as disparate as rodents and the plant Kalanchoe, treatment with these agents increases the period of the circadian clock by an amount just under an hour (16). In the budding yeast Saccharomyces. cerevisiae, there is a similar 30- to 40-min increase in period (17). Thus, in yeast, the period of the oscillation in the respiratory/reductive cycle is nearly doubled from 40 to ≈70 min. Close examination of the benchmark oscillation in dissolved oxygen (DO) in the gated synchrony system described here indicates that the reductive phase is exactly doubled whereas the length of the respiratory phase is unchanged by the drug. The presence of a genome-wide pattern of oscillation favors a view of the organization of cellular phenotype as a globally coupled dynamic structure. Representative genes from the three observed clusters (early reductive, late reductive, and respiratory) trace out a 3D structure. Collectively, all of the transcripts of the system can be pictured in concentration phase space as circling the steady state at a few opposed and equally spaced phase angles (18–23). The great strength of this view is that systems with large numbers of variables can be visualized in rather simple low-dimensional figures. These systems have a mathematical basis that has been well understood for some time (18). The rules of behavior are specific, and predictions can be readily tested in well controlled biological systems. Results In a previous study using Affymetrix chips and close time series sampling (every 4 min/32 chips/through three cycles), we showed that oscillations are a ubiquitous property of yeast transcripts (4). The temporal organization that gives rise to the well characterized 40-min oscillation (24–28) in DO is manifested in the sequestering of transcripts into those maximally expressed in the reductive phase and those maximally expressed in the respiratory phase. The reductive phase is roughly twice the length of the respiratory phase, and expression maxima are largely restricted to three equally spaced intervals in the cycle, one in the respiratory phase and two in the reductive phase. We have suggested that this transcriptional-respiratory-attractor cycle (TRAC) is responsible for the temporal organization of phenotype and for the timing of developmental processes such as the cell cycle. By mapping the genome-scale response to a perturbation known to change the oscillation period, some evidence of the dynamic structures underlying cellular phenotype may be revealed. Based on experiments following the changes in only the DO, carbon dioxide (CO2), and hydrogen sulfide (H2S) oscillations in response to PZ treatment (Fig. 6, which is published as supporting information on the PNAS web site), it was thought that the response, although rapid might, through close time sampling, allow a measure of the coupling strength and connectivity among genes and their transcripts. Treatment of cultures synchronous with respect to the TRAC and showing an ≈40-min DO oscillation results in a rapid response to PZ at doses between 0.5 and 3 mM. Lower doses have little effect on the period. The DO oscillation in response to 1 mM PZ showed that the period increased by 1.72. This increase was due to a nearly perfect doubling of the reductive phase (no oxygen utilization; high DO values), with little to no change in the duration of the respiratory phase (Figs. 1, 6, and 7, which is published as supporting information on the PNAS web site). In the color intensity map of Fig. 1
Measures of Periodicity in the Transcriptional Cycle. Fast Fourier transform filtering. To provide further support for the genome-wide nature of the oscillation in both the control and PZ-treated cultures, two standard methods, fast Fourier transform and singular value decomposition (SVD), were used to characterize transcript changes through time. Fourier filtering was used to class the transcripts according to where in the cycle they were maximally expressed and to determine whether maximum power was in the 40-min range in the first three cycles. Before beginning this classification, a decision rule for calling a particular transcript present was established. In our original study (4), we classed a transcript as present if it was present in at least 3 of the 11 samples taken for each cycle of the control series, leading to 5,432 transcripts being included in the analysis. If we raised the standard for inclusion to require that the transcript be present in all 32 samples, the number fell to 4,425 transcripts being classed as present. Using a similar classification system in this study and the default Affymetrix standards for a present call, we found that 5,328 were present in the PZ-treated experimental series when scored as present if present in at least three samples. If we raised the requirement to present in all samples, the number of transcripts scored as present fell to 4,429. Of these, 4,328 showed maximum power in the 40-min range by fast Fourier transform analysis (Fig. 9, which is published as supporting information on the PNAS web site). This amount is very similar to the number (4,311) found with maximum power at 40 min in the previously published control series. This analysis suggests that 4,328 (97.7%) of the 4,429 expressed genes show maximal power in the 40-min range. SVD. SVD has seen wide use in the analysis of expression array data and has proven to be a useful method for developing a global representation of expression profiles (29, 30). In our earlier study (4), shown here as the control, SVD uncovered the artifact in the data set that was caused by sampling from two different cultures with slightly different periods (Fig. 10, which is published as supporting information on the PNAS web site). The ability of the SVD application to find small differences between the two data sets in that series because of differences in phase and amplitude of the oscillation is a measure of its utility in studies of the transcriptional cycle. Having established the global pattern in the control series described in the earlier study (4), we next examined the information content of the Eigengenes (equivalent to eigenvectors 29,30) in the PZ-treated series involving a total of 5,328 expression patterns through 48 samples taken at 4-min intervals through four cycles of the oscillation. If SVD uncovers the details of the period-doubling response by a method designed to detect global features of the data, support for this finding would be enhanced. Information in the PZ-treated cultures is collected into the first four Eigengenes (Fig. 3
For comparison, a more transparent method was used. The average of the three major temporal clusters of Figs. 1 A third independent assessment of the genome-wide behavior of the TRAC was made by using self-organizing maps (SOM) and is presented in Movie 1 (which is published as supporting information on the PNAS web site) as an animation showing the cyclic pattern of changes through all four cycles of the experiment in transcripts clustered (31) using GEDI software (Fig. 14, which is published as supporting information on the PNAS web site). Concerted and Sequential Response to Perturbation. The period-doubling response seems to involve the entire genome and to take place rapidly, making an assessment of the sequence of specific changes difficult despite the frequent sampling. Nevertheless, one can assess those gene transcripts that change first and that change most dramatically as an indication of their immediacy in the drug response. In a globally coupled system, there is the expectation that those transcripts that are most tightly coupled to the initial responders will be the next to change and so on until the system as a whole has settled into a new basin of attraction. For the great majority of transcripts, the response was to show an increase or decrease in expression at the expected time rather than showing a phase shift. Transcripts were first sorted into groups based on their phase of maximum expression in the pretreatment cycle, as described in Figs. 1
Modeling the Dynamic Architecture of Phenotype. Qualitative similarities in the behavior of transcriptional oscillations described here to the trajectories taken by the variables in the systems of ordinary differential equations originally developed by Rössler (33) to represent biochemical or macromolecular regulatory loops are hard to ignore. The trajectory of the Rössler attractor was modified by translation into the positive quadrant and rotated to produce a model that more closely represented the behavior of the TRAC (Fig. 5
The increase in period of the oscillation occurs exclusively through a doubling of the reductive phase with the doubling in the number of peaks in expression during this time (Fig. 5 Discussion The gated synchrony system described here provides a unique opportunity to do true time series analysis. In this coherent population, all of the transcripts oscillate. Given this genome-wide oscillation, the only plausible way to think about a cell is as an oscillator, an attractor. Upon perturbation, the system shows a period-doubling response, one of the expected behaviors of deterministically noisy attractors. The envelope that contains the trajectories of all transcripts through phase space is similar to that described by the Rössler attractor. The TRAC oscillation is an expression of a complex, biological system with >5,000 transcripts and many more variables in toto. In dynamic systems theory, the formal representations that show the phenomenon of period doubling typically result from a change in the value of one of the parameters of the system equations, in which there are usually only three variables. To better represent this multivariable system, we earlier modeled the genome-wide properties of transcription by coupling multiple attractors each taken to represent a genetic regulatory loop of one or a few genes and their products and end products (22, 23). With yeast continuous cultures, we may now have a starting point for an experimental model for the period-doubling phenomenon and a means of testing some of the predictions of the simulations. If it can be generalized, the period-doubling phenomenon may represent a common pathway for differentiation. The idea that such phenotypic changes can be stably maintained as a consequence of their settling into a new stable basin of attraction or canal is not new (1). Because the period-doubling effect is confined to the reductive phase, the relative length of time spent in the reductive as opposed to the respiratory phase is increased. It is known that the ratio of respiration to glycolysis in this system is an accurate measure of the Warburg ratio, the relative amount of energy derived from glycolysis as opposed to respiration. It is reasonable to speculate that period doubling is a means by which the Warburg ratio is increased in other systems. Unrecognized Oscillations and the Reproducibility of Expression Microarrays. Concern has been growing that high through-put technologies, particularly expression microarrays (34), have shown a persistent barrier in sensitivity leading to the idea that there is a 2-fold boundary for change in the expression level of any gene transcript. Below the 2-fold boundary, calls are less certain. Although there is general agreement that the barrier within a particular microarray assay system is biological, no ready solution has been offered beyond increased numbers of biological replicates (34, 35). Doing more replicates might work if the cells or tissues are truly random in time or making transient excursions away from the steady state. However, taking increasing numbers of replicates, as many as 12 in some instances, has unexpected consequences if the system is universally oscillatory. If cells show highly organized temporal patterns of expression that go unrecognized, then repeated sampling and statistical analysis will yield a time-averaged value that is near the steady state of the oscillatory system but is not a value taken at any time during the oscillation. It is an artifact and guarantees that most of the genes with regular trajectories through concentration space will fall below the values needed to make a change call. Perfect randomness is likely to be as rare as perfect synchrony, and cells are not at a steady state. From the steady-state statistical perspective, it is not possible to show, on a gene by gene basis, that each gene transcript oscillates. However, in dynamic systems theory, there are classic papers that make the case that, in a coupled system where some of the elements are shown to oscillate, the likelihood that the system as a whole oscillates increases rapidly as the number of elements is increased beyond a rather small fraction of the total (36, 37). Conservation of Period. The temporal coordination manifested by the TRAC seems to involve essentially all cellular functions thus far examined. Given the alternation of the redox state, it should not be surprising to find that the alternation of respiration and reduction also extends to the functional state of the mitochondria (4, 38). Of current interest is the role that these high amplitude oscillations play in protein synthesis, degradation, and functional state. Transcripts for ubiquitin-proteosome function are made at just one phase of the cycle, suggesting that protein catabolism is temporally organized and oscillatory (4). This temporal organization extends to the synchronous gating of cells into S-phase. DNA replication in these cells begins abruptly at the end of the respiratory phase as oxygen consumption decreases and H2S levels rise. The restriction of DNA replication to the reductive phase of the cycle is seen as an evolutionarily important mechanism for preventing oxidative damage to DNA during replication. Moreover, conserved genes, those whose rate of substitution is in the lowest third of all genes, are transcribed almost exclusively in the reductive phase of the cycle. The idea that certain functional domains are conserved through great evolutionary distances is the core of our understanding of modern molecular evolution (39). Moreover, a number of papers have appeared showing that the rate of evolution of a protein is related to the number of measurable interactions, and the argument has been made that evolutionary changes may occur largely by coevolution (16). What has rarely, if ever, been considered is the idea that a dynamic property of the system might impose similar or greater constraints on its variation over time (40). An argument can be made for this idea based on the rapid genome-scale change in expression shown here. If, as we show, “everything oscillates,” then it is likely that, to a greater of lesser extent, every gene product interacts with some or many other gene products. In such a globally coupled system, the constraints on period change might be expected to be extreme. To put it another way, there may be a very limited path through which such change occurs and constraints on that path might be expected to follow a period-doubling bifurcation. Period mutants of the circadian clock and quantized generation times in cultured mammalian cells tend to cluster at a somewhat restricted set of values in the ≈4-h range (40, 41). The gating of yeast cells in the continuous synchrony cultures used here would seem to be another manifestation of this underlying timekeeper. In particular, ≈40 min, ≈80 min, and ≈240 min (4 h) are the most frequently seen. However, a recent study using a different yeast strain grown in limiting glucose and under high oxygen tension showed an ≈5-h DO oscillation and a similar pattern of transcriptional oscillations to that reported here and earlier (42, 43). In nonlinear dynamic systems, the TRAC and most of the temporal organization associated with it seem to be maintained through the period-doubling process. This path is significant in representing period doubling and, perhaps, period three bifurcations. An intriguing question is whether this behavior generalizes to mammalian cells and to stem cell differentiation. Methods Medium and Culture Conditions. The fermenter (650 ml) was inoculated with 2 × 107 cells of the yeast strain IFO0233 and grown as described (4) except glucose monohydrate was added at 19.25 g/liter (Sigma, St. Louis, MO). Antifoam A was added at 0.2 ml/liter, and the pH was maintained at 4.0. To maintain oscillations, cultures were shifted from batch to continuous mode at a dilution rate of 0.086/h. Phenelzine (cat. no. 156136; MP Biomedicals, Solon, OH) was added at the reductive phase. RNA Preparation. RNA was purified and processed for Affymetrix GeneChip analysis as described in Supporting Methods, which is published as supporting information on the PNAS web site. RNA yield differences between samples were normalized by adding Affymetrix poly(A) standards to the cell pellets at the beginning of RNA isolation. Data Analysis. Results were quantified and analyzed by using MicroArray Suite 6.1 and GCOS software. Excel files were created to permit further processing and then put into Mathcad (Mathsoft Inc., Cambridge, MA), Mathematica (Wolfram Research, Champaign, IL), SigmaPlot, or in MatLab (Mathworks Inc., Natick, MA). Intensity values for each of the verified ORFs in the S98 chip and the yeast S2 chip were linked to the Saccharomyces Genome Database (SGD) site, and both their genetic and physical map locations were associated with the intensity values for each gene as described (4). The results for all ORFs scored as present by using the default Affymetrix settings were identified according to the original sample number and the phase in the DO oscillation at which the maximum expression occurred. Expression patterns were then mapped according to the time of maximum as a starting point for presentation. Further analysis was performed for all ORFs present in all samples in each of the four cycles. Of the 5,443 ORFs scored as present in at least 3 of the 48 samples, 5,254 had P values <0.01 and the remainder had P values <0.035 (detailed methods and sample calculations are available in Supporting Methods). Original data are available from the National Center for Biotechnology Information/Gene Expression Omnibus web site. Supporting Information
Acknowledgments We thank Paul Frankel of the Biostatistics Department for help in translating the Rössler attractor, Maricela Covarrubias of the Functional Genomics core facility for help with sample preparation and analysis, Ariel Klevecz of the Dynamics Group for help with informatics and early experiments with PZ and monoamine oxidase homologues, and Tim Synold and the Mass Spectrometry Core Facility for analysis of PZ levels in cells and medium. Abbreviations Footnotes The authors declare no conflict of interest. This article is a PNAS direct submission. See Commentary on page 16063. References 1. Waddington CD. The Strategy of the Gene. London: Allen and Unwin; 1957. 2. Nicolis G, Prigogine I. Proc Natl Acad Sci USA. 1971;68:2102–2107. [PubMed] 3. Mackey MC, Glass L. Science. 1977;197:287–289. [PubMed] 4. Klevecz RR, Bolen J, Forrest G, Murray DB. Proc Natl Acad Sci USA. 2004;101:1200–1205. [PubMed] 5. Klevecz RR, Ruddle FH. Science. 1968;59:634–636. [PubMed] 6. Kauffman S, Wille JJ. J Theor Biol. 1975;55:47–93. [PubMed] 7. Klevecz RR, Kros J, Gross SD. Exp Cell Res. 1978;116:285–290. [PubMed] 8. Sharan R, Ideker T. Nat Biotechnol. 2000;24:427–433. [PubMed] 9. Tao WA, Wollscheid B, O'Brien R, Eng JK, Li XJ, Bodenmiller B, Watts JD, Hood L, Aebersold R. Nat Methods. 2005;2:591–598. [PubMed] 10. Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, Eng JK, Aderem A, Boyle R, Brunner E, Donohoe S, et al. Genome Biol. 2005;6:R9. [PubMed] 11. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, et al. Nature. 2005;437:1173–1178. [PubMed] 12. Macisaac KD, Gordon DB, Nekludova L, Odom DT, Schreiber J, Gifford DK, Young RA, Fraenkel E. Bioinformatics. 2006;22:423–429. [PubMed] 13. Fraser HB, Hirsh AE, Steinmetz LM, Scharfe C, Feldman MW. Science. 2002;296:750–752. [PubMed] 14. Johnsson A, Engelmann W, Pflug B, Klemke W. Int J Chronobiol. 1983;8:129–147. [PubMed] 15. Johnsson A, Engelmann W, Pflug B, Klemke W. Z Naturforsch C. 1980;35:503–507. [PubMed] 16. Engelmann W, Bollig I, Hartmann R. Arzneimittelforschung. 1976;26:1085–1086. [PubMed] 17. Salgado E, Murray DB, Lloyd D. Biol Rhythm Res. 2002;33:351–361. 18. Noszticzius Z, McCormick WD, Swinney HL. J Phys Chem. 1989;93:2796–2800. 19. Kreisberg N, McCormick WD, Swinney HL. J Chem Phys. 1989;91:6532–6533. 21. Ott E, Grebogi C, Yorke JA. Phys Rev Lett. 1990;64:1196–1199. [PubMed] 22. Klevecz RR, Bolen JL, Duran O. Int J Bifurcation Chaos. 1992;2:941–953. 23. Bolen JL, Duran O, Klevecz RR. Physica D. 1993;67:245–256. 24. Murray DB, Klevecz RR, Lloyd D. Exp Cell Res. 2003;287:10–15. [PubMed] 25. Satroutdinov AD, Kuriyama H, Kobayashi H. FEMS Microbiol Lett. 1992;77:261–267. [PubMed] 26. Murray DB, Engelen F, Lloyd D, Kuriyama H. Microbiology. 1999;145:2739–2745. [PubMed] 27. Mochan E, Pye EK. Nat New Biol. 1973;242:177–179. [PubMed] 28. Poole RK, Lloyd D. Biochem J. 1973;136:195–207. [PubMed] 29. Alter O, Brown PO, Botstein D. Proc Natl Acad Sci USA. 2000;97:10101–10106. [PubMed] 30. Alter O, Brown PO, Botstein D. Proc Natl Acad Sci USA. 2003;100:3351–3356. [PubMed] 31. de Bivort B, Huang S, Bar-Yam Y. Proc Natl Acad Sci USA. 2004;101:17687–17692. [PubMed] 32. Murray M, Greenberg ML. Mol Microbiol. 1997;25:541–546. [PubMed] 33. Rössler OE. Z Naturforsch. 1976;31A:259–264. 34. Dobbin K, Simon R. Biostatistics. 2005;6:27–38. [PubMed] 35. Wang SJ, Chen JJ. J Comput Biol. 2004;11:714–726. [PubMed] 36. Hess B, Boiteux A. Annu Rev Biochem. 1971;40:237–258. [PubMed] 37. Rubin H, Sitgreaves R. Tech Rep No 19. Stanford, CA: Stanford Univ Dept Statistics; 1954. 38. Lloyd D, Salgado LE, Turner MP, Suller MT, Murray D. Microbiology. 2002;148:3715–3724. [PubMed] 39. Ohno S. Evolution by Gene Duplication. Berlin: Springer; 1970. 40. Klevecz RR. In: Cellular Oscillators as Vestiges of a Primitive Circadian Clock in Cell Cycle Clocks. Edmunds L, editor. New York: Dekker; 1984. 41. Klevecz RR. Proc Natl Acad Sci USA. 1976;73:4012–4016. [PubMed] 42. Tu BP, Kudlicki A, Rowicka M, McKnight SL. Science. 2005;310:1152. [PubMed] 43. Reinke H., Gatfield D. Trends Biochem Sci. 2006;31:189–191. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Proc Natl Acad Sci U S A. 1971 Sep; 68(9):2102-2107.
[Proc Natl Acad Sci U S A. 1971]Science. 1977 Jul 15; 197(4300):287-9.
[Science. 1977]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Science. 1968 Feb 9; 159(815):634-6.
[Science. 1968]J Theor Biol. 1975 Nov; 55(1):47-93.
[J Theor Biol. 1975]Int J Chronobiol. 1983; 8(3):129-47.
[Int J Chronobiol. 1983]Z Naturforsch C. 1980 May-Jun; 35(5-6):503-7.
[Z Naturforsch C. 1980]Arzneimittelforschung. 1976; 26(6):1085-6.
[Arzneimittelforschung. 1976]Phys Rev Lett. 1990 Mar 12; 64(11):1196-1199.
[Phys Rev Lett. 1990]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Exp Cell Res. 2003 Jul 1; 287(1):10-5.
[Exp Cell Res. 2003]FEMS Microbiol Lett. 1992 Nov 1; 77(1-3):261-7.
[FEMS Microbiol Lett. 1992]Microbiology. 1999 Oct; 145 ( Pt 10)():2739-45.
[Microbiology. 1999]Nat New Biol. 1973 Apr 11; 242(119):177-9.
[Nat New Biol. 1973]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 2000 Aug 29; 97(18):10101-6.
[Proc Natl Acad Sci U S A. 2000]Proc Natl Acad Sci U S A. 2003 Mar 18; 100(6):3351-6.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 2004 Dec 21; 101(51):17687-92.
[Proc Natl Acad Sci U S A. 2004]Mol Microbiol. 1997 Aug; 25(3):541-6.
[Mol Microbiol. 1997]Biostatistics. 2005 Jan; 6(1):27-38.
[Biostatistics. 2005]J Comput Biol. 2004; 11(4):714-26.
[J Comput Biol. 2004]Annu Rev Biochem. 1971; 40():237-58.
[Annu Rev Biochem. 1971]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Microbiology. 2002 Nov; 148(Pt 11):3715-24.
[Microbiology. 2002]Arzneimittelforschung. 1976; 26(6):1085-6.
[Arzneimittelforschung. 1976]Proc Natl Acad Sci U S A. 1976 Nov; 73(11):4012-6.
[Proc Natl Acad Sci U S A. 1976]Science. 2005 Nov 18; 310(5751):1152-8.
[Science. 2005]Trends Biochem Sci. 2006 Apr; 31(4):189-91.
[Trends Biochem Sci. 2006]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1200-5.
[Proc Natl Acad Sci U S A. 2004]